Home / Stocks / CADL

CADL insider trading

Candel Therapeutics, Inc. — open-market insider buys and $1M+ sells from SEC Forms 3, 4 and 5.
Insider buys · 24 mo
2
Bought · 24 mo
$10.5M
Buys · last 90 days
0 · $0
Most recent buy
2026-02-26

Recent insider filings

FiledInsiderTypeSharesPriceValue
2026-09-11Tak Paul Peter
Chief Executive Officer
Sold220,866$11.50$2.5M
2026-02-26Manning Paul B
Director
Bought550,458$5.45$3.0M
2024-12-18Manning Paul B
Director
Bought1,250,000$6.00$7.5M

Most active insider buyers

InsiderRoleBuysTotal bought
Manning Paul BDirector2$10.5M

See CADL on the chart

Every insider buy and sell for CADL plotted on the price, the full two-year history, cluster scores and daily updates — in the members area, $29/month. A free quarterly sample of the whole dataset needs no account.

Open the browserFree sample
Data from the SEC EDGAR ownership filings, refreshed daily. Only open-market purchases (transaction code P) and sales of $1M or more are shown; grants, option exercises and tax withholding are excluded because they run on schedules set years earlier. Not investment advice.